Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments.
about
Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysisUnfractionated heparin for hemodialysis: still the best option.What are the anticoagulation options for intermittent hemodialysis?Alternatives to standard unfractionated heparin for pediatric hemodialysis treatmentsThe rationale for the use of low molecular weight heparin for hemodialysis treatments.Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis.Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysisA multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane studyDo higher dialysate calcium concentrations increase vascular stiffness in haemodialysis patients as measured by aortic pulse wave velocity?Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised TrialTissue plasminogen activator versus heparin for locking dialysis catheters: A systematic reviewHemodialysis for infants, children, and adolescents.Low-molecular weight heparin infusion as anticoagulation for haemodialysis.Histidine-rich glycoprotein functions cooperatively with cell surface heparan sulfate on phagocytes to promote necrotic cell uptake.Spontaneous gall bladder haemorrhage in a renal dialysis patient following haemodialysis with tinzaparin.Infection Rates Following Buttonhole Cannulation in Hemodialysis Patients.The effect of vegetarian diet on skin autofluorescence measurements in haemodialysis patients.Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients.Influence of heparin molecular size on the induction of C- terminal unfolding in β2-microglobulin.Differences in prescribed Kt/V and delivered haemodialysis dose--why obesity makes a difference to survival for haemodialysis patients when using a 'one size fits all' Kt/V target.Does hemodiafiltration reduce vascular stiffness measured by aortic pulse wave velocity compared with high-flux hemodialysis?Pharmacologic treatment in dialysis patients hospitalized for cardiovascular reasons: do we follow the guidelines?Platelet activation and clotting cascade activation by dialyzers designed for high volume online hemodiafiltration.Can enoxaparin be used safely in end-stage renal disease?Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration.Renal unit practitioners' knowledge, attitudes and practice regarding the safety of unfractionated heparin for chronic haemodialysis.Clinical safety and anticoagulation efficacy of low-molecular-weight heparins in chronic hemodialysis patients: a single medical center experience.Changes in muscle and fat mass with haemodialysis detected by multi-frequency bioelectrical impedance analysis.Patients' perspective of haemodialysis-associated symptoms.Changes in body composition following haemodialysis as assessed by bioimpedance spectroscopy.Dialysis and Patient Factors Which Determine Convective Volume Exchange in Patients Treated by Postdilution Online Hemodiafiltration.Changes in Vascular Tone Occur Early During Hemodialysis Treatments Independently of Volume Reduction.
P2860
Q27002491-4D3D1511-8418-4DD0-8799-1A01E341228FQ33392592-3AED3150-0171-411B-A01E-70F451C6E1CAQ33396089-5081BDEF-464C-4E16-A48F-024FC776A804Q33399961-D60E0A87-B43A-4466-BF27-89FCE5706CA7Q33410982-982F03A8-BD7E-4A48-B0FF-1C47531C2599Q33442494-7BB321EB-F93E-46EB-B2C7-A6474A4BC609Q33762788-5BAF8929-5B79-43F5-AFC4-E21DF1C7E7B4Q34320163-647AE9A1-C2BF-4C8F-AC3F-7A1753D4798CQ34980427-E8AA3F65-E3AE-4A18-9AD7-54975FA46CDEQ35663917-A43660B9-92BA-45F8-B4E5-A8D8BFA0A267Q38064861-5228DC19-959F-4D39-B0CB-8A75DF3EE7E0Q38203967-539DD213-7D83-4EBB-8D8F-8B1BA6E912A1Q38835775-A04774C8-3C26-4B9F-8251-5FF0EF39D7F8Q39688969-AC416225-FFA6-4C97-88ED-9B694E8F8F8AQ40331982-143EF391-25BC-41EB-B2E0-4A9218F098F7Q40503620-C38A8DFB-F0C1-4BA1-9EA0-A36EA7BCFC0CQ41244290-0CC2FC9F-644E-4296-B647-12835D066953Q41715138-91FC5D39-60DD-4750-9ABE-A592EF3C4AF4Q42319844-5F6C90DC-AE9F-4AB0-857E-AEEB770FDB1BQ44298753-0B78A3C3-1562-42C0-935E-75B75F0A681FQ44441064-A8FCF931-11DD-46D3-9A86-9227BA3C8671Q45784975-5FFC920A-9CF9-4CA6-A01E-85561345E27EQ45870306-14F7FCF4-6CFE-4834-AFCE-2E6B7D407D2EQ46094670-B6D96FA2-B1B8-42E4-BDEA-2C2F455B7C3BQ46532216-50AE2673-E98F-40C9-92BB-2A96F6016F45Q46571673-EA677D0D-6FFC-420E-BE0B-D62562DF4DFEQ47348747-B540759E-37F2-48FB-A68A-86A0DBACA0FEQ48179740-CA963B46-2EAC-4036-B4CD-2C0B00768FF9Q48713316-ACABCAFE-B0C4-4828-8054-AB57F9FE70C3Q51152195-78921F0A-784E-42E4-85CC-B4D8D1D92FEEQ53091077-BC2CEEE5-5514-4455-A93F-115D4894FDDCQ53661306-954EF8FD-F3A9-4164-9A63-AE9F3CAE91C5
P2860
Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Review article: Low-molecular- ...... ient haemodialysis treatments.
@ast
Review article: Low-molecular- ...... ient haemodialysis treatments.
@en
type
label
Review article: Low-molecular- ...... ient haemodialysis treatments.
@ast
Review article: Low-molecular- ...... ient haemodialysis treatments.
@en
prefLabel
Review article: Low-molecular- ...... ient haemodialysis treatments.
@ast
Review article: Low-molecular- ...... ient haemodialysis treatments.
@en
P1433
P1476
Review article: Low-molecular- ...... ient haemodialysis treatments.
@en
P2093
Andrew Davenport
P304
P356
10.1111/J.1440-1797.2009.01135.X
P577
2009-08-01T00:00:00Z